![](/img/cover-not-exists.png)
LBA6_PRCOMBI-AD: Adjuvant dabrafenib (D) plus trametinib (T) for resected stage III BRAF V600E/K–mutant melanoma
Hauschild, A., Santinami, M., Long, G.V., Atkinson, V., Mandala, M., Chiarion Sileni, V., Nyakas, M.S., Dutriaux, C., Haydon, A., Robert, C., Mortier, L., Schachter, J., Ji, R., Zhang, P., Mookerjee,Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx440.046
Date:
September, 2017
File:
PDF, 94 KB
english, 2017